{
  "company": {
    "name": "ImmunityBio",
    "website": "https://immunitybio.com/",
    "record": "https://startuphistory.org/c/immunitybio.com"
  },
  "status": null,
  "history_since": "2019-07-19T19:20:38.000Z",
  "baseline": {
    "snapshot_id": "8f675921433db38f2e92df346b298bd0f8542a2dd65736d72d8761daa13fdcdd",
    "observed_at": "2019-07-19T19:20:38.000Z",
    "headline": null,
    "description": "ImmunityBio, a privately held immunotherapy company with a broad portfolio of over 40 biological molecules spanning first-in-class next-generation cytokine antibodies (Nantibody), fusion proteins, mon",
    "evidence": "https://web.archive.org/web/20190719192038/https://immunitybio.com/",
    "evidence_kind": "internet_archive",
    "facts": null,
    "basis": "first_observation",
    "is_change": false
  },
  "live_captures": 1,
  "last_checked": "2026-11-06T17:22:41.701Z",
  "live_status": null,
  "messaging": [
    {
      "quote_observed_at": "2020-07-11T12:18:39.000Z",
      "variants": [
        {
          "headline": "ImmunityBio, Inc.",
          "subhead": null,
          "observed_at": "2020-07-11T12:18:39.000Z",
          "evidence": "https://web.archive.org/web/20200711121839/https://immunitybio.com/",
          "evidence_kind": "internet_archive"
        }
      ],
      "headline": "ImmunityBio, Inc.",
      "subhead": null,
      "from": "2020-07-11T12:18:39.000Z",
      "to": "2020-07-11T12:18:39.000Z",
      "captures": 1,
      "evidence": "https://web.archive.org/web/20200711121839/https://immunitybio.com/",
      "evidence_kind": "internet_archive",
      "seen": {
        "on": "2020-07-11T12:18:39.000Z"
      },
      "current": false
    },
    {
      "quote_observed_at": "2022-01-05T11:55:00.000Z",
      "variants": [
        {
          "headline": "Outsmart Your Disease ™",
          "subhead": "ImmunityBio is dedicated to conquering cancer. We develop therapies that kill disease, not the immune system. Learn about our investigational immunotherapy and cell therapy products.",
          "observed_at": "2022-01-05T11:55:00.000Z",
          "evidence": "https://web.archive.org/web/20220105115500/https://immunitybio.com/",
          "evidence_kind": "internet_archive"
        }
      ],
      "headline": "Outsmart Your Disease ™",
      "subhead": "ImmunityBio is dedicated to conquering cancer. We develop therapies that kill disease, not the immune system. Learn about our investigational immunotherapy and cell therapy products.",
      "from": "2022-01-05T11:55:00.000Z",
      "to": "2022-01-05T11:55:00.000Z",
      "captures": 1,
      "evidence": "https://web.archive.org/web/20220105115500/https://immunitybio.com/",
      "evidence_kind": "internet_archive",
      "seen": {
        "on": "2022-01-05T11:55:00.000Z"
      },
      "current": false
    },
    {
      "quote_observed_at": "2022-07-04T20:42:08.000Z",
      "variants": [
        {
          "headline": "Finding Better Treatments for Bladder Cancer",
          "subhead": "ImmunityBio is dedicated to conquering cancer. We develop therapies that kill disease, not the immune system. Learn about our investigational immunotherapy and cell therapy products.",
          "observed_at": "2022-07-04T20:42:08.000Z",
          "evidence": "https://web.archive.org/web/20220704204208/https://immunitybio.com/",
          "evidence_kind": "internet_archive"
        }
      ],
      "headline": "Finding Better Treatments for Bladder Cancer",
      "subhead": "ImmunityBio is dedicated to conquering cancer. We develop therapies that kill disease, not the immune system. Learn about our investigational immunotherapy and cell therapy products.",
      "from": "2022-07-04T20:42:08.000Z",
      "to": "2022-07-04T20:42:08.000Z",
      "captures": 1,
      "evidence": "https://web.archive.org/web/20220704204208/https://immunitybio.com/",
      "evidence_kind": "internet_archive",
      "seen": {
        "on": "2022-07-04T20:42:08.000Z"
      },
      "current": false
    },
    {
      "quote_observed_at": "2023-07-05T03:08:45.000Z",
      "variants": [
        {
          "headline": "Researching Ways to Prevent Cancer",
          "subhead": "ImmunityBio is dedicated to conquering cancer. We develop therapies that kill disease, not the immune system. Learn about our investigational immunotherapy and cell therapy products.",
          "observed_at": "2023-07-05T03:08:45.000Z",
          "evidence": "https://web.archive.org/web/20230705030845/https://immunitybio.com/",
          "evidence_kind": "internet_archive"
        }
      ],
      "headline": "Researching Ways to Prevent Cancer",
      "subhead": "ImmunityBio is dedicated to conquering cancer. We develop therapies that kill disease, not the immune system. Learn about our investigational immunotherapy and cell therapy products.",
      "from": "2023-07-05T03:08:45.000Z",
      "to": "2023-07-05T03:08:45.000Z",
      "captures": 1,
      "evidence": "https://web.archive.org/web/20230705030845/https://immunitybio.com/",
      "evidence_kind": "internet_archive",
      "seen": {
        "on": "2023-07-05T03:08:45.000Z"
      },
      "current": false
    },
    {
      "quote_observed_at": "2024-01-01T12:53:26.000Z",
      "variants": [
        {
          "headline": "Outsmart Your Disease ®",
          "subhead": "ImmunityBio is dedicated to conquering cancer. We develop therapies that kill disease, not the immune system. Learn about our investigational immunotherapy and cell therapy products.",
          "observed_at": "2024-01-01T12:53:26.000Z",
          "evidence": "https://web.archive.org/web/20240101125326/https://immunitybio.com/",
          "evidence_kind": "internet_archive"
        }
      ],
      "headline": "Outsmart Your Disease ®",
      "subhead": "ImmunityBio is dedicated to conquering cancer. We develop therapies that kill disease, not the immune system. Learn about our investigational immunotherapy and cell therapy products.",
      "from": "2024-01-01T12:53:26.000Z",
      "to": "2024-01-01T12:53:26.000Z",
      "captures": 1,
      "evidence": "https://web.archive.org/web/20240101125326/https://immunitybio.com/",
      "evidence_kind": "internet_archive",
      "seen": {
        "on": "2024-01-01T12:53:26.000Z"
      },
      "current": false
    },
    {
      "quote_observed_at": "2025-01-08T16:32:13.000Z",
      "variants": [
        {
          "headline": "ANKTIVA’s permanent J Code, J9028, is active for billing purposes effective Jan 1, 2025",
          "subhead": "We're dedicated to defeating cancer with therapies that target disease, not immune systems. Find our investigational immunotherapy and cell therapy products.",
          "observed_at": "2025-01-08T16:32:13.000Z",
          "evidence": "https://web.archive.org/web/20250108163213/https://immunitybio.com/",
          "evidence_kind": "internet_archive"
        }
      ],
      "headline": "ANKTIVA’s permanent J Code, J9028, is active for billing purposes effective Jan 1, 2025",
      "subhead": "We're dedicated to defeating cancer with therapies that target disease, not immune systems. Find our investigational immunotherapy and cell therapy products.",
      "from": "2025-01-08T16:32:13.000Z",
      "to": "2025-01-08T16:32:13.000Z",
      "captures": 1,
      "evidence": "https://web.archive.org/web/20250108163213/https://immunitybio.com/",
      "evidence_kind": "internet_archive",
      "seen": {
        "on": "2025-01-08T16:32:13.000Z"
      },
      "current": false
    },
    {
      "quote_observed_at": "2025-07-05T01:39:35.000Z",
      "variants": [
        {
          "headline": "FDA Approved Expanded Access of Cancer Bioshield™ to treat Solid Tumor Lymphopenia",
          "subhead": "We're dedicated to defeating cancer with therapies that target disease, not immune systems. Find our investigational immunotherapy and cell therapy products.",
          "observed_at": "2025-07-05T01:39:35.000Z",
          "evidence": "https://web.archive.org/web/20250705013935/https://immunitybio.com/",
          "evidence_kind": "internet_archive"
        }
      ],
      "headline": "FDA Approved Expanded Access of Cancer Bioshield™ to treat Solid Tumor Lymphopenia",
      "subhead": "We're dedicated to defeating cancer with therapies that target disease, not immune systems. Find our investigational immunotherapy and cell therapy products.",
      "from": "2025-07-05T01:39:35.000Z",
      "to": "2025-07-05T01:39:35.000Z",
      "captures": 1,
      "evidence": "https://web.archive.org/web/20250705013935/https://immunitybio.com/",
      "evidence_kind": "internet_archive",
      "seen": {
        "on": "2025-07-05T01:39:35.000Z"
      },
      "current": false
    },
    {
      "quote_observed_at": "2026-07-29T05:54:07.000Z",
      "variants": [
        {
          "headline": "ImmunityBio Announces Exclusive U.S. Deal for Tokyo-Strain BCG",
          "subhead": "We're dedicated to defeating cancer with therapies that target disease, not immune systems. Find our investigational immunotherapy and cell therapy products.",
          "observed_at": "2026-07-29T05:54:07.000Z",
          "evidence": "https://web.archive.org/web/20260729055407/https://immunitybio.com/",
          "evidence_kind": "internet_archive"
        }
      ],
      "headline": "ImmunityBio Announces Exclusive U.S. Deal for Tokyo-Strain BCG",
      "subhead": "We're dedicated to defeating cancer with therapies that target disease, not immune systems. Find our investigational immunotherapy and cell therapy products.",
      "from": "2026-07-29T05:54:07.000Z",
      "to": "2026-07-29T05:54:07.000Z",
      "captures": 1,
      "evidence": "https://web.archive.org/web/20260729055407/https://immunitybio.com/",
      "evidence_kind": "internet_archive",
      "seen": {
        "on": "2026-07-29T05:54:07.000Z"
      },
      "current": false
    },
    {
      "quote_observed_at": "2026-11-06T17:22:41.701Z",
      "variants": [
        {
          "headline": "ImmunityBio Announces First Patients in Europe Treated with ANKTIVA®+BCG",
          "subhead": "We're dedicated to defeating cancer with therapies that target disease, not immune systems. Find our investigational immunotherapy and cell therapy products.",
          "observed_at": "2026-11-06T17:22:41.701Z",
          "evidence": "https://immunitybio.com/",
          "evidence_kind": "live_capture"
        }
      ],
      "headline": "ImmunityBio Announces First Patients in Europe Treated with ANKTIVA®+BCG",
      "subhead": "We're dedicated to defeating cancer with therapies that target disease, not immune systems. Find our investigational immunotherapy and cell therapy products.",
      "from": "2026-11-06T17:22:41.701Z",
      "to": "2026-11-06T17:22:41.701Z",
      "captures": 1,
      "evidence": "https://immunitybio.com/",
      "evidence_kind": "live_capture",
      "seen": {
        "on": "2026-11-06T17:22:41.701Z"
      },
      "current": true
    }
  ],
  "changes": [
    {
      "n": 1,
      "id": "page-8f675921433db38f2e92df346b298bd0f8542a2dd65736d72d8761daa13fdcdd:8f98e32d23e9140aba47add07b497765dad6a010152c79805f0b438c65404410:hiring:20dd4c09cc4ab0aa",
      "before_evidence": "https://web.archive.org/web/20190719192038/https://immunitybio.com/",
      "before_evidence_kind": "internet_archive",
      "kind": "hiring",
      "label": "Hiring",
      "summary": "Added a careers page.",
      "between": {
        "from": "2019-07-19T19:20:38.000Z",
        "to": "2020-07-11T12:18:39.000Z"
      },
      "evidence": "https://web.archive.org/web/20200711121839/https://immunitybio.com/",
      "evidence_kind": "internet_archive",
      "basis": "page_facts",
      "topic": "https://startuphistory.org/t/added-careers-page"
    },
    {
      "n": 2,
      "id": "page-03a339f9e08639c6b7a6b6ee3b1cea14169273b6883d0ad599813e683fc747e5:42d9e9a2dff7b9a1f5b6df43461fa2a6777cd04141a450fca114a36c912644cc:headline:4bafb0233e80b6f4",
      "before_evidence": "https://web.archive.org/web/20220105115500/https://immunitybio.com/",
      "before_evidence_kind": "internet_archive",
      "kind": "headline",
      "label": "Headline",
      "summary": "Changed its homepage headline from “Outsmart Your Disease ™” to “Finding Better Treatments for Bladder Cancer”.",
      "between": {
        "from": "2022-01-05T11:55:00.000Z",
        "to": "2022-07-04T20:42:08.000Z"
      },
      "evidence": "https://web.archive.org/web/20220704204208/https://immunitybio.com/",
      "evidence_kind": "internet_archive",
      "basis": "page_facts",
      "topic": null
    },
    {
      "n": 3,
      "id": "page-42d9e9a2dff7b9a1f5b6df43461fa2a6777cd04141a450fca114a36c912644cc:25da5b3c94dd175693cb62c2775f690ad53267f7ebf642c6aa3cf368996165c0:headline:37564100ed422e2c",
      "before_evidence": "https://web.archive.org/web/20220704204208/https://immunitybio.com/",
      "before_evidence_kind": "internet_archive",
      "kind": "headline",
      "label": "Headline",
      "summary": "Changed its homepage headline from “Finding Better Treatments for Bladder Cancer” to “Researching Ways to Prevent Cancer”.",
      "between": {
        "from": "2022-07-04T20:42:08.000Z",
        "to": "2023-07-05T03:08:45.000Z"
      },
      "evidence": "https://web.archive.org/web/20230705030845/https://immunitybio.com/",
      "evidence_kind": "internet_archive",
      "basis": "page_facts",
      "topic": null
    },
    {
      "n": 4,
      "id": "page-25da5b3c94dd175693cb62c2775f690ad53267f7ebf642c6aa3cf368996165c0:ce07182dfa11a41616c6bcdd30787503ad2d161c077e2b705071502422025525:headline:7363fd225cfe92de",
      "before_evidence": "https://web.archive.org/web/20230705030845/https://immunitybio.com/",
      "before_evidence_kind": "internet_archive",
      "kind": "headline",
      "label": "Headline",
      "summary": "Changed its homepage headline from “Researching Ways to Prevent Cancer” to “Outsmart Your Disease ®”.",
      "between": {
        "from": "2023-07-05T03:08:45.000Z",
        "to": "2024-01-01T12:53:26.000Z"
      },
      "evidence": "https://web.archive.org/web/20240101125326/https://immunitybio.com/",
      "evidence_kind": "internet_archive",
      "basis": "page_facts",
      "topic": null
    },
    {
      "n": 5,
      "id": "page-ce07182dfa11a41616c6bcdd30787503ad2d161c077e2b705071502422025525:afc0cb3a6bd676d693a37928dcd74870bf432caf4327159d0e4b4e5a1a333c84:headline:b195e53384b619c9",
      "before_evidence": "https://web.archive.org/web/20240101125326/https://immunitybio.com/",
      "before_evidence_kind": "internet_archive",
      "kind": "headline",
      "label": "Headline",
      "summary": "Changed its homepage headline from “Outsmart Your Disease ®” to “ANKTIVA’s permanent J Code, J9028, is active for billing purposes effective Jan 1, 2025”.",
      "between": {
        "from": "2024-01-01T12:53:26.000Z",
        "to": "2025-01-08T16:32:13.000Z"
      },
      "evidence": "https://web.archive.org/web/20250108163213/https://immunitybio.com/",
      "evidence_kind": "internet_archive",
      "basis": "page_facts",
      "topic": null
    },
    {
      "n": 6,
      "id": "page-afc0cb3a6bd676d693a37928dcd74870bf432caf4327159d0e4b4e5a1a333c84:07a5b6dd99ca278bd6323d6d4a9be3a6185278075de7ec201fdf44f06581dde9:headline:f4f957b28d2d52af",
      "before_evidence": "https://web.archive.org/web/20250108163213/https://immunitybio.com/",
      "before_evidence_kind": "internet_archive",
      "kind": "headline",
      "label": "Headline",
      "summary": "Changed its homepage headline from “ANKTIVA’s permanent J Code, J9028, is active for billing purposes effective Jan 1, 2025” to “FDA Approved Expanded Access of Cancer Bioshield™ to treat Solid Tumor Lymphopenia”.",
      "between": {
        "from": "2025-01-08T16:32:13.000Z",
        "to": "2025-07-05T01:39:35.000Z"
      },
      "evidence": "https://web.archive.org/web/20250705013935/https://immunitybio.com/",
      "evidence_kind": "internet_archive",
      "basis": "page_facts",
      "topic": null
    },
    {
      "n": 7,
      "id": "page-afc0cb3a6bd676d693a37928dcd74870bf432caf4327159d0e4b4e5a1a333c84:07a5b6dd99ca278bd6323d6d4a9be3a6185278075de7ec201fdf44f06581dde9:compliance:896e777391705078",
      "before_evidence": "https://web.archive.org/web/20250108163213/https://immunitybio.com/",
      "before_evidence_kind": "internet_archive",
      "kind": "compliance",
      "label": "Compliance",
      "summary": "Now states FDA APPROVED and FDA-APPROVED compliance on its homepage.",
      "between": {
        "from": "2025-01-08T16:32:13.000Z",
        "to": "2025-07-05T01:39:35.000Z"
      },
      "evidence": "https://web.archive.org/web/20250705013935/https://immunitybio.com/",
      "evidence_kind": "internet_archive",
      "basis": "page_facts",
      "topic": "https://startuphistory.org/t/added-compliance"
    },
    {
      "n": 8,
      "id": "page-07a5b6dd99ca278bd6323d6d4a9be3a6185278075de7ec201fdf44f06581dde9:1246106837ecc53fc0cf6ef1e3fbf1d1e6bfead41932b72f228e368cfa830001:headline:413895fbb3798079",
      "before_evidence": "https://web.archive.org/web/20250705013935/https://immunitybio.com/",
      "before_evidence_kind": "internet_archive",
      "kind": "headline",
      "label": "Headline",
      "summary": "Changed its homepage headline from “FDA Approved Expanded Access of Cancer Bioshield™ to treat Solid Tumor Lymphopenia” to “ImmunityBio Announces Exclusive U.S. Deal for Tokyo-Strain BCG”.",
      "between": {
        "from": "2025-07-05T01:39:35.000Z",
        "to": "2026-07-29T05:54:07.000Z"
      },
      "evidence": "https://web.archive.org/web/20260729055407/https://immunitybio.com/",
      "evidence_kind": "internet_archive",
      "basis": "page_facts",
      "topic": null
    },
    {
      "n": 9,
      "id": "page-1246106837ecc53fc0cf6ef1e3fbf1d1e6bfead41932b72f228e368cfa830001:9107b2440c442f4097afd5b10234a729ef58aadbccefa60df07d46be1fd33848:headline:5fc33fe7d0be223e",
      "before_evidence": "https://web.archive.org/web/20260729055407/https://immunitybio.com/",
      "before_evidence_kind": "internet_archive",
      "kind": "headline",
      "label": "Headline",
      "summary": "Changed its homepage headline from “ImmunityBio Announces Exclusive U.S. Deal for Tokyo-Strain BCG” to “ImmunityBio Announces First Patients in Europe Treated with ANKTIVA®+BCG”.",
      "between": {
        "from": "2026-07-29T05:54:07.000Z",
        "to": "2026-11-06T17:22:41.701Z"
      },
      "evidence": "https://immunitybio.com/",
      "evidence_kind": "live_capture",
      "basis": "page_facts",
      "topic": null
    }
  ],
  "update": null,
  "method": {
    "version": "messaging-v1",
    "description": "https://startuphistory.org/method"
  },
  "license": "CC-BY-4.0",
  "cite": "StartupHistory, “ImmunityBio” company record, https://startuphistory.org/c/immunitybio.com"
}